Literature DB >> 29759352

A Systematic Review on the Progression of Paroxysmal to Persistent Atrial Fibrillation: Shedding New Light on the Effects of Catheter Ablation.

Riccardo Proietti1, Alexios Hadjis2, Ahmed AlTurki2, George Thanassoulis2, Jean-François Roux3, Atul Verma4, Jeff S Healey5, Martin L Bernier2, David Birnie6, Stanley Nattel7, Vidal Essebag8.   

Abstract

The progression from paroxysmal atrial fibrillation (AF) to persistent or long-term persistent forms has recently gained increasing attention. A growing amount of data has shown a significant morbidity and mortality associated with the transition. The aim of our systematic review was to assess the evidence regarding AF progression rates with different management approaches. Electronic databases were searched by using text words and relevant indexing to capture data on AF progression. Studies that considered progression from paroxysmal AF to a persistent or permanent form were included. The papers collected were divided into 2 groups: 1) general population studies (with almost exclusively medical therapy); and 2) studies that consider progression of AF subsequent to AF ablation. Twenty-one studies were included in the first group and 8 in the second group. In the first group, percentage of AF progression at 1 year ranged from 10% to 20%. Studies that included a longer follow-up detected a higher percentage of progression (from 50% to 77% after 12 years). In patients treated with catheter ablation, the percentage of progression was significantly lower (from 2.4% to 2.7% at 5 years' follow-up). The percentage of progression after catheter ablation did not change according to duration of follow-up. AF ablation is associated with significantly reduced progression to persistent forms compared with studies in the general population. Prevention of long-term AF progression may be a clinically relevant outcome after AF ablation. Further research is required to determine whether delaying progression of AF by catheter ablation reduces morbidity and mortality.
Copyright © 2015 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  atrial fibrillation; catheter ablation; progression

Year:  2015        PMID: 29759352     DOI: 10.1016/j.jacep.2015.04.010

Source DB:  PubMed          Journal:  JACC Clin Electrophysiol        ISSN: 2405-500X


  13 in total

1.  Diagnosis-to-Ablation Time and Recurrence of Atrial Fibrillation Following Catheter Ablation: A Systematic Review and Meta-Analysis of Observational Studies.

Authors:  Derek S Chew; Eric Black-Maier; Zak Loring; Peter A Noseworthy; Douglas L Packer; Derek V Exner; Daniel B Mark; Jonathan P Piccini
Journal:  Circ Arrhythm Electrophysiol       Date:  2020-03-19

2.  Stroke rates before and after ablation of atrial fibrillation and in propensity-matched controls in the UK.

Authors:  Julian We Jarman; Tina D Hunter; Wajid Hussain; Jamie L March; Tom Wong; Vias Markides
Journal:  Pragmat Obs Res       Date:  2017-05-29

3.  Mortality, stroke, and heart failure in atrial fibrillation cohorts after ablation versus propensity-matched cohorts.

Authors:  Julian We Jarman; Tina D Hunter; Wajid Hussain; Jamie L March; Tom Wong; Vias Markides
Journal:  Pragmat Obs Res       Date:  2017-05-29

4.  Cost-Effectiveness of Extended and One-Time Screening Versus No Screening for Non-Valvular Atrial Fibrillation in the USA.

Authors:  Mustafa Oguz; Tereza Lanitis; Xiaoyan Li; Gail Wygant; Daniel E Singer; Keith Friend; Patrick Hlavacek; Andreas Nikolaou; Soeren Mattke
Journal:  Appl Health Econ Health Policy       Date:  2020-08       Impact factor: 2.561

5.  Incidence and Predictors of Atrial Fibrillation Progression.

Authors:  Steffen Blum; Stefanie Aeschbacher; Pascal Meyre; Leon Zwimpfer; Tobias Reichlin; Jürg H Beer; Peter Ammann; Angelo Auricchio; Richard Kobza; Paul Erne; Giorgio Moschovitis; Marcello Di Valentino; Dipen Shah; Jürg Schläpfer; Selina Henz; Christine Meyer-Zürn; Laurent Roten; Matthias Schwenkglenks; Christian Sticherling; Michael Kühne; Stefan Osswald; David Conen
Journal:  J Am Heart Assoc       Date:  2019-10-08       Impact factor: 5.501

6.  Longer diagnosis-to-ablation time is associated with recurrence of atrial fibrillation after catheter ablation-Systematic review and meta-analysis.

Authors:  Raymond Pranata; Veresa Chintya; Sunu B Raharjo; Muhammad Yamin; Yoga Yuniadi
Journal:  J Arrhythm       Date:  2019-12-27

7.  Persistent atrial fibrillation over 3 years is associated with higher recurrence after catheter ablation.

Authors:  Hee Tae Yu; In-Soo Kim; Tae-Hoon Kim; Jae-Sun Uhm; Jong-Youn Kim; Boyoung Joung; Moon-Hyoung Lee; Hui-Nam Pak
Journal:  J Cardiovasc Electrophysiol       Date:  2020-01-15

8.  N-Terminal Pro B-Type Natriuretic Peptide's Usefulness for Paroxysmal Atrial Fibrillation Detection Among Populations Carrying Cardiovascular Risk Factors.

Authors:  Elena Palà; Alejandro Bustamante; Josep Lluis Clúa-Espuny; Juan Acosta; Felipe Gonzalez-Loyola; Juan Ballesta-Ors; Natalia Gill; Andrea Caballero; Jorge Pagola; Alonso Pedrote; Miguel Angel Muñoz; Joan Montaner
Journal:  Front Neurol       Date:  2019-11-29       Impact factor: 4.003

Review 9.  Targeting the Substrate in Ablation of Persistent Atrial Fibrillation: Recent Lessons and Future Directions.

Authors:  Martin K Stiles; Prashanthan Sanders; Dennis H Lau
Journal:  Front Physiol       Date:  2018-09-18       Impact factor: 4.566

Review 10.  Subclinical Atrial Fibrillation and Risk of Stroke: Past, Present and Future.

Authors:  Ahmed AlTurki; Mariam Marafi; Vincenzo Russo; Riccardo Proietti; Vidal Essebag
Journal:  Medicina (Kaunas)       Date:  2019-09-20       Impact factor: 2.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.